FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220706179> ?p ?o ?g. }

• W4220706179 endingPage "1133" @default.
• W4220706179 startingPage "1126" @default.
• W4220706179 abstract "To identify individual characteristics associated with serological COVID-19 vaccine responsiveness and the durability of vaccine-induced antibodies.Adults without history of SARS-CoV-2 infection from the Danish population scheduled for SARS-CoV-2 vaccination were enrolled in this parallel group, phase 4 study. SARS-CoV-2 Spike IgG and Spike-ACE2-receptor-blocking antibodies were measured at days 0, 21, 90, and 180. Vaccine responsiveness was categorized according to Spike IgG and Spike-ACE2-receptor-blocking levels at day 90 after first vaccination. Nondurable vaccine response was defined as day-90 responders who no longer had significant responses by day 180.Of 6544 participants completing two vaccine doses (median age 64 years; interquartile range: 54-75), 3654 (55.8%) received BTN162b2, 2472 (37.8%) mRNA-1273, and 418 (6.4%) ChAdOx1 followed by an mRNA vaccine. Levels of both types of antibodies increased from baseline to day 90 and then decreased to day 180. The decrease was more pronounced for levels of Spike-ACE2-receptor-blocking antibodies than for Spike IgG. Proportions with vaccine hyporesponsiveness and lack of durable response were 5.0% and 12.1% for Spike IgG and 12.7% and 39.6% for Spike-ACE2-receptor-blocking antibody levels, respectively. Male sex, vaccine type, and number of comorbidities were associated with all four outcomes. Additionally, age ≥75 years was associated with hyporesponsiveness for Spike-ACE2-receptor-blocking antibodies (adjusted odds ratio: 1.59; 95% confidence interval: 1.25-2.01) but not for Spike IgG.Comorbidity, male sex, and vaccine type were risk factors for hyporesponsiveness and nondurable response to COVID-19 vaccination. The functional activity of vaccine-induced antibodies declined with increasing age and had waned to pre-second-vaccination levels for most individuals after 6 months." @default.
• W4220706179 created "2022-04-03" @default.
• W4220706179 creator A5005421754 @default.
• W4220706179 creator A5008991000 @default.
• W4220706179 creator A5009895696 @default.
• W4220706179 creator A5011023321 @default.
• W4220706179 creator A5011518654 @default.
• W4220706179 creator A5019135530 @default.
• W4220706179 creator A5019482614 @default.
• W4220706179 creator A5027126440 @default.
• W4220706179 creator A5028156447 @default.
• W4220706179 creator A5036947467 @default.
• W4220706179 creator A5041413555 @default.
• W4220706179 creator A5047831950 @default.
• W4220706179 creator A5049151623 @default.
• W4220706179 creator A5051110000 @default.
• W4220706179 creator A5058188603 @default.
• W4220706179 creator A5060569928 @default.
• W4220706179 creator A5064654936 @default.
• W4220706179 creator A5065087670 @default.
• W4220706179 creator A5066846892 @default.
• W4220706179 creator A5068045868 @default.
• W4220706179 creator A5070561278 @default.
• W4220706179 creator A5074394409 @default.
• W4220706179 creator A5079979177 @default.
• W4220706179 creator A5080120008 @default.
• W4220706179 creator A5082182829 @default.
• W4220706179 creator A5084732553 @default.
• W4220706179 creator A5085051687 @default.
• W4220706179 creator A5086897371 @default.
• W4220706179 creator A5088269941 @default.
• W4220706179 creator A5089536645 @default.
• W4220706179 date "2022-08-01" @default.
• W4220706179 modified "2023-10-06" @default.
• W4220706179 title "Characteristics associated with serological COVID-19 vaccine response and durability in an older population with significant comorbidity: the Danish Nationwide ENFORCE Study" @default.
• W4220706179 cites W2019896390 @default.
• W4220706179 cites W2148356388 @default.
• W4220706179 cites W3102328262 @default.
• W4220706179 cites W3111255098 @default.
• W4220706179 cites W3111590711 @default.
• W4220706179 cites W3121008609 @default.
• W4220706179 cites W3148255637 @default.
• W4220706179 cites W3171697212 @default.
• W4220706179 cites W3176527986 @default.
• W4220706179 cites W3183923345 @default.
• W4220706179 cites W3186421507 @default.
• W4220706179 cites W3196397911 @default.
• W4220706179 cites W3197484199 @default.
• W4220706179 cites W3198862438 @default.
• W4220706179 cites W3202826390 @default.
• W4220706179 cites W3208073486 @default.
• W4220706179 cites W3210126657 @default.
• W4220706179 cites W3214771257 @default.
• W4220706179 cites W3215143364 @default.
• W4220706179 cites W4200066927 @default.
• W4220706179 cites W4205483821 @default.
• W4220706179 doi "https://doi.org/10.1016/j.cmi.2022.03.003" @default.
• W4220706179 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35283313" @default.
• W4220706179 hasPublicationYear "2022" @default.
• W4220706179 type Work @default.
• W4220706179 citedByCount "27" @default.
• W4220706179 countsByYear W42207061792022 @default.
• W4220706179 countsByYear W42207061792023 @default.
• W4220706179 crossrefType "journal-article" @default.
• W4220706179 hasAuthorship W4220706179A5005421754 @default.
• W4220706179 hasAuthorship W4220706179A5008991000 @default.
• W4220706179 hasAuthorship W4220706179A5009895696 @default.
• W4220706179 hasAuthorship W4220706179A5011023321 @default.
• W4220706179 hasAuthorship W4220706179A5011518654 @default.
• W4220706179 hasAuthorship W4220706179A5019135530 @default.
• W4220706179 hasAuthorship W4220706179A5019482614 @default.
• W4220706179 hasAuthorship W4220706179A5027126440 @default.
• W4220706179 hasAuthorship W4220706179A5028156447 @default.
• W4220706179 hasAuthorship W4220706179A5036947467 @default.
• W4220706179 hasAuthorship W4220706179A5041413555 @default.
• W4220706179 hasAuthorship W4220706179A5047831950 @default.
• W4220706179 hasAuthorship W4220706179A5049151623 @default.
• W4220706179 hasAuthorship W4220706179A5051110000 @default.
• W4220706179 hasAuthorship W4220706179A5058188603 @default.
• W4220706179 hasAuthorship W4220706179A5060569928 @default.
• W4220706179 hasAuthorship W4220706179A5064654936 @default.
• W4220706179 hasAuthorship W4220706179A5065087670 @default.
• W4220706179 hasAuthorship W4220706179A5066846892 @default.
• W4220706179 hasAuthorship W4220706179A5068045868 @default.
• W4220706179 hasAuthorship W4220706179A5070561278 @default.
• W4220706179 hasAuthorship W4220706179A5074394409 @default.
• W4220706179 hasAuthorship W4220706179A5079979177 @default.
• W4220706179 hasAuthorship W4220706179A5080120008 @default.
• W4220706179 hasAuthorship W4220706179A5082182829 @default.
• W4220706179 hasAuthorship W4220706179A5084732553 @default.
• W4220706179 hasAuthorship W4220706179A5085051687 @default.
• W4220706179 hasAuthorship W4220706179A5086897371 @default.
• W4220706179 hasAuthorship W4220706179A5088269941 @default.
• W4220706179 hasAuthorship W4220706179A5089536645 @default.
• W4220706179 hasBestOaLocation W42207061791 @default.
• W4220706179 hasConcept C119060515 @default.
• W4220706179 hasConcept C126322002 @default.
• W4220706179 hasConcept C159047783 @default.

• next